ASK1 promotes the contact hypersensitivity response through IL-17 production

Area of Science:

• Immunology
• Dermatology

Background:

• Contact hypersensitivity (CHS) is a T-cell-mediated inflammatory skin response.
• Reactive haptens trigger sensitization and elicitation phases in CHS.
• Interleukin-17 (IL-17) is a key cytokine in CHS pathogenesis.

Purpose of the Study:

• To investigate the role of Apoptosis signal-regulating kinase 1 (ASK1) in CHS.
• To determine if ASK1 inhibition during elicitation can attenuate CHS.
• To explore the impact of ASK1 suppression on IL-17 production.

Main Methods:

• Utilized ASK1 knockout (KO) mice to assess CHS response to 2,4-dinitrofluorobenzene (DNFB).
• Employed chemical genetic approaches and specific inhibitors to suppress ASK1 activity during the elicitation phase.
• Quantified IL-17 production from sensitized lymph node cells.

Main Results:

• ASK1 KO mice showed impaired DNFB-induced CHS.
• Suppression of ASK1 during elicitation significantly reduced CHS severity, comparable to KO mice.
• Reduced CHS correlated with significantly inhibited IL-17 production.

Conclusions:

• ASK1 plays a crucial role in the elicitation phase of CHS.
• Inhibiting ASK1 during elicitation is sufficient to attenuate CHS.
• ASK1 inhibition reduces IL-17 production, highlighting its therapeutic potential for allergic contact dermatitis and IL-17-related inflammatory conditions.